Fakultni Nemocnice Plzen — Clinical Trial Site

98 Registered trials

32 Currently recruiting

Organisation

Fakultni Nemocnice Plzen

Location

Plzen 23, Czechia

Identifier

ORG-100017307

Address

Edvarda Benese 1128/13, Jizni Predmesti, 301 00, Czechia

Departments

#2010: Hematoonkologicke-onkologicke oddeleni
#2022:Ústav imunologie a alergologie
#40748: Dermatology
1904: Hematologicko-onkologicke odd.
1905: II. Interni klinika
2003 :Dermatovenerologicka klinika, Edvarda Benese
2030010:Ocni klinika
203005; Hematologicko-onkologicke odd.
20303:Ocni klinika
2202: Hematologicko-onkologicke oddeleni
2328: II. interní klinika
2542: Dermatovenerologicka klinika
3052:Kardiologická klinika
40748:Dermatovenerologicka klinika
9102; Dermatologicka klinika
Cardiology Department
Department of Cardiology
Department of Dermatovenerology
Department of Hematology and Oncology
Department of Obstetrics and Gynecology
Department of Pediatrics
Dermatovenereology Department
Dermatovenerologicka klinika
Dermatovenerology
Dětská klinika
Fakultni Nemocnice Plzen( #1)
FN Plzen Hematologicko-onkologicke oddeleni
gynaecology - obstetrics clinic
Haemato-oncology
Haematology and Oncology
Hemato-Oncology
Hemato-oncology department
Hemato-onkologicke oddeleni
Hematologicko-onkologické oddělení
Hematologicko-onkologické oddělení FN Plzeň
Hepatologická poradna I. Interní klinika FN Plzeň
I. Internal clinic
I. interní klinika
II interni klinika - centrum preventivni kardiologie
II. Internal Clinic
II. Interni klinika
II. Interni klinika
II. interní klinika / II. Internal Clinic
Intensive care unit
Internal clinic
Kardiologická klinika
Kardiologické oddělení-arytmologie
Klinika anesteziologie, resuscitace a intenzivní medicíny
Klinika pneumologie a ftizeologie
Klinika zobrazovacích metod - Lochotín
Klinika zobrazovacích metod-Lochotín
N/A
NA
Nefrologie - I. interní klinika
Oční klinika
Oddělení klinické Alergologie a Imunologie
oncology
Onkologická a radioterapeutická klinika
Otorinolaryngologicka klinika
Urologicka klinika
Urology
Ústav imunologie a alergologie
Z97CZ10005: Hematologicko-onkologicke odd.

Clinical trials at this site (98)

Search interface

A trial to test the effect of obicetrapib/ezetimibe on coronary plaque characteristics on coronary computerized tomography angiography in pe… Recruiting

2023-508475-36-00 Atherosclerotic Cardiovascular Disease 5 2024-10-29
202301CPC Redefine-HF Recruiting

2023-508581-15-00 Heart condition 5 2024-10-08
A study to learn how bimekizumab works in children and teenagers with moderate to severe plaque psoriasis Recruiting

2023-503859-10-00 Moderate to Severe Plaque Psoriasis 5 2024-08-12
Phase III study to evaluate the effect of balcinrenone/dapagliflozin in patients with heart failure and impaired kidney function Recruiting

2023-508162-15-00 Chronic HF and comorbid impairment of kidney function w 5 2024-07-12
A Study of Daratumumab, Bortezomib, Lenalidomide and Dexamethasone (DVRd) Followed by Ciltacabtagene Autoleucel Versus Daratumumab, Bortezom… Recruiting

2023-507632-20-00 Multiple Myeloma 5 2024-05-01
CARE1: FIRST LINE RANDOMISED STUDY PLATFORM TO OPTIMIZE TREATMENT IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA Recruiting

2023-503317-29-00 Metastatic renal cell carcinoma (mRCC) 5 2024-04-12
An international randomised trial of radical surgery followed by adjuvant therapy versus no further treatment in patients with early-stage, … Recruiting

2023-504973-19-01 early-stage, intermediate-risk cervical cancer 5 2023-09-06
A study to evaluate the efficacy and safety of QMF149 (indacaterol acetate/mometasone furoate) versus Budesonide in children from 6 to less … Recruiting

2022-501899-26-00 Asthma 5 2023-09-01
A Phase 3 Randomized Study Comparing Teclistamab in Combination with Daratumumab SC and Lenalidomide (Tec-DR) and Talquetamab in Combination… Recruiting

2023-503442-30-00 Multiple Myeloma 5 2022-10-14
Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone versus Lenalidomide Alone in Participants With Newly Dia… Recruiting

2023-510384-36-00 Newly Diagnosed Multiple Myeloma 5 2022-09-13
Asciminib Roll-over Study Recruiting

2023-507557-16-00 chronic myelogenous leukemia (CML) or Philadelphia Chro 5 2022-08-31
A Phase 3 Study Comparing Pirtobrutinib to Ibrutinib in CLL/SLL Recruiting

2023-507699-38-00 Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma 5 2022-08-30
Selatogrel Outcome Study in Suspected Acute Myocardial Infarction Recruiting

2023-505438-85-00 Acute myocardial infarction (AMI) 5 2022-01-12
Goal directed fluid removal in critically ill patients with fluid overload Recruiting

2024-512186-14-00 Fluid overload/fluid accumulation 6 2020-08-24
Extension study to assess effects of non-interrupted versus interrupted and long term treatment of two dose regimens on efficacy and safety … Recruiting

2023-508956-20-00 Hidradenitis suppurativa 5 2020-03-12
A Phase 3 Study to Evaluate the Efficacy and Safety of Ritlecitinib in Children 6 to <12 Years of Age With Severe Alopecia Areata Ended

2024-515438-33-00 Alopecia areata 5 2026-01-12
MK-2870 versus Chemotherapy in Previously Treated or Metastatic Nonsquamous Non-small Cell Lung Cancer (NSCLC) with EGFR Mutations or Other … Ended

2023-503539-16-00 Non-small Cell Lung Cancer (NSCLC) 5 2025-11-11
A Study of Two Doses of Ritlecitinib in People 12 Years of Age and Older with Alopecia Areata Ended

2024-519370-40-00 Alopecia areata 5 2025-07-16
A Phase 3 study to assess the efficacy, safety, and tolerability of itepekimab (antiIL33 mAb) in participants with inadequately-controlled… Ended

2024-516815-26-00 Chronic rhinosinusitis with nasal polyps 5 2025-05-30
A trial to learn how safe AZD8630 is and how well it works in adults with uncontrolled asthma. Ended

2024-514228-18-00 Asthma in adults who remain uncontrolled despite medium 4 2025-01-16
ARTEMIS - A research study to look at how ziltivekimab works compared to placebo in people who have had a heart attack Ended

2023-506876-28-00 The medical condition we are investigating is type 1 AM 5 2024-08-01
A Study to Compare the Efficacy and Safety of Golcadomide Plus R-CHOP vs Placebo Plus R-CHOP in Participants with Previously Untreated High-… Ended

2023-510178-15-00 High-risk Large B-cell Lymphoma 5 2024-07-31
A Phase 3, Open-Label, Randomized Study of Sonrotoclax (BGB-11417) Plus Zanubrutinib (BGB-3111) Compared With Venetoclax Plus Obinutuzumab i… Ended

2023-506948-17-00 Previously Untreated Chronic Lymphocytic Leukemia 5 2024-04-05
A Phase 3 Study of Front‑line Platinum Doublet Therapy With Sotorasib Versus Pembrolizumab in PD-L1 Negative KRAS p.G12C Positive Advanced/M… Ended

2022-501863-41-00 Subjects With Stage IV or Advanced Stage IIIB/C Nonsqua 5 2023-11-13